Header Ads

Drugmakers seek FDA emergency authorization for molnupiravir, antiviral pill to treat COVID-19: Latest updates

Merck & Co. and Ridgeback Biotherapeutics announced Monday the submission of emergency use authorization to the FDA for molnupiravir. COVID updates.

     


from USATODAY - News Top Stories https://ift.tt/3lsiSbZ

Merck & Co. and Ridgeback Biotherapeutics announced Monday the submission of emergency use authorization to the FDA for molnupiravir. COVID updates.

     
October 11, 2021 at 11:40AM https://ift.tt/3Bvaxde https://ift.tt/3lsiSbZ

No comments

Powered by Blogger.